Advanced Genomic Technology
Advanced Genomic Technology is a private, Louisville, Kentucky-based biotechnology company founded in 2005 by Eugenia Wang (Founder & CEO) operating in the genomics space with 1-10 employees. No products, customers, funding, or commercial details are disclosed in available sources.
- Company typePrivate
- Founded2005
- HeadquartersLouisville, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Advanced Genomic Technology does
Advanced Genomic Technology (AGT) is a private biotechnology company headquartered in Louisville, Kentucky, founded in 2005 by Eugenia Wang, who continues to serve as Founder and CEO. The company operates in the genomics space, based on its name and the founder's profile, but the source material does not specify its product lines, technical platform, target indications, or end markets. The company maintains a web presence at advancedgenomictechnology.com, though the current page contains only a tracking pixel and a privacy preference link with no substantive product, service, or corporate content.
The company's organizational footprint is small, with 1-10 employees reported and no disclosed funding rounds, acquisitions, partnerships, customer relationships, intellectual property holdings, or management team beyond the founder. No revenue, ARR, or contract value figures are disclosed. The absence of disclosed products, pricing, or distribution channels means the business model cannot be characterized in any detail; the company may be engaged in undisclosed R&D, consulting, or laboratory services, but this is not supported by the available evidence.
From an investment-evaluation standpoint, the available data describes the firm's basic existence but provides essentially no operational, commercial, or financial signals. The 20-year gap between founding (2005) and the current effectively dormant public footprint is a notable signal that warrants direct diligence before any commercial-relationship or investment assumption is made.
Advanced Genomic Technology firmographics
Firmographics- Name
- Advanced Genomic Technology
- Website
- https://advancedgenomictechnology.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Advanced Genomic Technology is a private, Louisville, Kentucky-based biotechnology company founded in 2005 by Eugenia Wang (Founder & CEO) operating in the genomics space with 1-10 employees. No products, customers, funding, or commercial details are disclosed in available sources.
- Ownership category
- akta.pro rank
Advanced Genomic Technology industry classification
Industry- Product category
- Biotechnology Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)
- akta.pro secondary industries
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
Keywords
Where Advanced Genomic Technology is headquartered
LocationHeadquarters
- HQ city
- Louisville
- HQ country
- United States
- HQ region
- North America
Markets served
Advanced Genomic Technology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations
Advanced Genomic Technology product offering
Product offeringCore offering
Advanced Genomic Technology is a privately held biotechnology firm founded in 2005 and based in Louisville, Kentucky. The company's specific products, services, or research focus are not described in the available source data; the company website contains only a tracking pixel and a privacy preference link with no substantive company content.
Product overview
No product information available in the source data.
Differentiator
Problem solved
Functional benefit
Companies that use Advanced Genomic Technology
Customer profileIdeal customer profiles1 record
Advanced Genomic Technology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Advanced Genomic Technology partnerships and signals
Strategic signalRecent moves1 record
Advanced Genomic Technology competitors and assessment
Company assessmentDirect peers
- 23andMe: Consumer and clinical genetic testing company with a direct overlap to AGT's genomic testing category. Comparable as a small/mid-stage player offering DNA-based services to consumers and researchers.
- Natera: Clinical genetic testing company focused on reproductive health, oncology, and organ transplant monitoring. Directly comparable in service category (genomic testing) and target customer (clinicians/labs).
- Invitae: Medical genetics company offering genetic testing across multiple clinical areas. Direct peer in offering genomic testing services to healthcare providers and patients.
- Guardant Health: Precision oncology company specializing in liquid biopsy and genomic profiling. Comparable in applying genomic technology to clinical diagnostics, with a similar molecular biology platform foundation.
- Personalis: Genomics company developing clinical-grade whole-genome sequencing and immunotherapy diagnostics. Comparable as a smaller-scale genomics player with technology-driven differentiation in molecular testing.
Broad incumbents
- Myriad Genetics: Established molecular diagnostics company offering genetic tests across hereditary cancer, pharmacogenomics, and prenatal health. Operates in the same genetic/genomic testing category as AGT but at much larger scale and breadth.
- NeoGenomics: Oncology-focused clinical laboratory services provider with broad genomic and molecular diagnostic capabilities. Comparable in operating in clinical genomics diagnostics space.
- Illumina: Dominant provider of next-generation sequencing technology and platforms that underpin most genomic testing workflows. Comparable as the broad incumbent enabling the genomics category AGT operates in.
- Foundation Medicine: Molecular diagnostics company (Roche subsidiary) providing comprehensive genomic profiling of tumors. Operates in the same clinical genomics category as AGT.
- Quest Diagnostics: Large clinical laboratory network offering genomic and molecular diagnostic tests alongside routine lab work. Comparable as a broad incumbent offering genetic/genomic testing services.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights3 records
Customer concentration
Advanced Genomic Technology social profiles
Digital presenceAdvanced Genomic Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Advanced Genomic Technology leadership team
Management profileNumber of profiles
Profiles1 record
Advanced Genomic Technology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Advanced Genomic Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Advanced Genomic Technology
What does Advanced Genomic Technology do?
Advanced Genomic Technology is a privately held biotechnology firm founded in 2005 and based in Louisville, Kentucky. The company's specific products, services, or research focus are not described in the available source data; the company website contains only a tracking pixel and a privacy preference link with no substantive company content.
Is Advanced Genomic Technology a public or private company?
Advanced Genomic Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Advanced Genomic Technology founded?
Advanced Genomic Technology was founded in 2005. It employs 1 to 10 people.
Where is Advanced Genomic Technology based?
Advanced Genomic Technology is headquartered in Louisville, United States, in the North America region.
Who are Advanced Genomic Technology's main competitors?
Direct peers on record are 23andMe, Natera, Invitae, Guardant Health and Personalis. Broad incumbents are Myriad Genetics, NeoGenomics, Illumina, Foundation Medicine and Quest Diagnostics.
Does Advanced Genomic Technology have an API?
No public API is recorded for Advanced Genomic Technology.
What industry is Advanced Genomic Technology in?
Advanced Genomic Technology's product category is Biotechnology Services. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services. Its NAICS code is 541714 and its SIC code is 8731.